Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Genome Editing/Genome Engineering Market - Global Forecast to 2021 - Market is Undergoing a Significant Transformation - Research and Markets

Research and Markets
Posted on: 17 Oct 16

Research and Markets has announced the addition of the "Genome Editing/Genome Engineering Market - Global Forecast to 2021" report to their offering.

The genome editing market is projected to reach USD 5.54 billion by 2021 from USD 2.84 billion in 2016, growing at a CAGR of 14.3% in the next five years (2016 to 2021). The genome editing market is undergoing a significant transformation, with the changing landscapes of healthcare, and manufacturing industries. The growth of this market is majorly influenced by the dynamics of these industries.

Factors such as rising government funding and growth in the number of genomics projects, high prevalence rate of infectious diseases and cancer among patients, technological advancements, increasing demand for synthetic genes, growing awareness about genomics, and increasing new product launches by industry players are expected to drive the genome editing market in the coming years. Rise in the production of genetically modified crops is also expected to increase the demand for genome editing. However, the high cost of genomic equipment, shortage of trained professionals, and adverse public perception related to genetic research are restraining the growth of the market to a certain extent.

Increasing use of genome editing in specialized/personalized medicine and emerging markets in developing countries like Brazil, China, and India are providing various growth opportunities for players in the genome editing market.

Companies Mentioned:

  • Genscript Usa Inc.
  • Horizon Discovery Group Plc
  • Integrated Dna Technologies, Inc.
  • Lonza Group Ltd.
  • Merck Kgaa
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Sangamo Biosciences, Inc.
  • Thermo Fisher Scientific, Inc.
  • Transposagen Biopharmaceuticals, Inc.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Global Genome Editing/Engineering Market, By Technology

7 Global Genome Editing/Genome Engineering Market, By Application

8 Global Genome Editing/Engineering Market, By End User

9 Genome Editing/Genome Engineering Market, By Region

10 Competitive Landscape

11 Company Profiles

12 Appendix

For more information about this report visit http://www.researchandmarkets.com/research/8dvkwl/genome

View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005522/en/

Business Wire
www.businesswire.com

Last updated on: 17/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.